187 related articles for article (PubMed ID: 19167045)
1. Relationship between cysteinyl-leukotriene-1 receptor and human transitional cell carcinoma in bladder.
Matsuyama M; Funao K; Hayama T; Tanaka T; Kawahito Y; Sano H; Takemoto Y; Nakatani T; Yoshimura R
Urology; 2009 Apr; 73(4):916-21. PubMed ID: 19167045
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of cysteinyl LT1 receptor in prostate cancer and CysLT1R antagonist inhibits prostate cancer cell growth through apoptosis.
Matsuyama M; Hayama T; Funao K; Kawahito Y; Sano H; Takemoto Y; Nakatani T; Yoshimura R
Oncol Rep; 2007 Jul; 18(1):99-104. PubMed ID: 17549353
[TBL] [Abstract][Full Text] [Related]
3. Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder.
Elsamman E; Fukumori T; Kasai T; Nakatsuji H; Nishitani MA; Toida K; Ali N; Kanayama HO
BJU Int; 2006 Jun; 97(6):1202-7. PubMed ID: 16686711
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte colony-stimulating factor/granulocyte colony-stimulating factor receptor biological axis promotes survival and growth of bladder cancer cells.
Chakraborty A; Guha S
Urology; 2007 Jun; 69(6):1210-5. PubMed ID: 17572226
[TBL] [Abstract][Full Text] [Related]
5. Expression of chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) in bladder transitional cell carcinoma.
Ham WS; Lee JH; Yu HS; Choi YD
Urology; 2008 Oct; 72(4):921-6. PubMed ID: 18387660
[TBL] [Abstract][Full Text] [Related]
6. [Expression of melanoma antigen gene in urinary transitional cell carcinomas].
Geng L; Yu LZ; Du P; Ma M; Na YQ
Zhonghua Wai Ke Za Zhi; 2005 May; 43(10):667-71. PubMed ID: 16008943
[TBL] [Abstract][Full Text] [Related]
7. The cysteinylLT1 receptor in human renal cell carcinoma.
Funao K; Matsuyama M; Naganuma T; Kawahito Y; Sano H; Nakatani T; Yoshimura R
Mol Med Rep; 2008; 1(2):185-9. PubMed ID: 21479395
[TBL] [Abstract][Full Text] [Related]
8. [Expression of cyclooxygenase-2 in bladder transitional cell carcinoma and the significance thereof].
Yu L; Chen XJ; Shi PQ; Ding Q; Sun CH; Liu GB; Shi DM; Huang YG
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(38):2683-4. PubMed ID: 19080686
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinase-10 in human bladder transitional cell carcinoma.
Seargent JM; Loadman PM; Martin SW; Naylor B; Bibby MC; Gill JH
Urology; 2005 Apr; 65(4):815-20. PubMed ID: 15833553
[TBL] [Abstract][Full Text] [Related]
10. Identification of survivin, an inhibitor of apoptosis, in canine urinary bladder transitional cell carcinoma.
Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Rucker EB; Knapp DW; Rodriguez CO; Green JA
Vet Comp Oncol; 2008 Sep; 6(3):141-50. PubMed ID: 19178674
[TBL] [Abstract][Full Text] [Related]
11. Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas.
Ohd JF; Nielsen CK; Campbell J; Landberg G; Löfberg H; Sjölander A
Gastroenterology; 2003 Jan; 124(1):57-70. PubMed ID: 12512030
[TBL] [Abstract][Full Text] [Related]
12. Translational studies of glutathione in bladder cancer cell lines and human specimens.
Pendyala L; Velagapudi S; Toth K; Zdanowicz J; Glaves D; Slocum H; Perez R; Huben R; Creaven PJ; Raghavan D
Clin Cancer Res; 1997 May; 3(5):793-8. PubMed ID: 9815751
[TBL] [Abstract][Full Text] [Related]
13. Activation of CysLT receptors induces astrocyte proliferation and death after oxygen-glucose deprivation.
Huang XJ; Zhang WP; Li CT; Shi WZ; Fang SH; Lu YB; Chen Z; Wei EQ
Glia; 2008 Jan; 56(1):27-37. PubMed ID: 17910051
[TBL] [Abstract][Full Text] [Related]
14. A novel localization of the G-protein-coupled CysLT1 receptor in the nucleus of colorectal adenocarcinoma cells.
Nielsen CK; Campbell JI; Ohd JF; Mörgelin M; Riesbeck K; Landberg G; Sjölander A
Cancer Res; 2005 Feb; 65(3):732-42. PubMed ID: 15705869
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.
Olbert PJ; Schrader AJ; Simon C; Dalpke A; Barth P; Hofmann R; Hegele A
Anticancer Res; 2009 Jun; 29(6):2067-76. PubMed ID: 19528466
[TBL] [Abstract][Full Text] [Related]
16. Expression of cysteinylLT1 receptor in human testicular cancer and growth reduction by its antagonist through apoptosis.
Matsuyama M; Funao K; Kawahito Y; Sano H; Chargui J; Touraine JL; Nakatani T; Yoshimura R
Mol Med Rep; 2009; 2(2):163-7. PubMed ID: 21475807
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene D4 induces brain edema and enhances CysLT2 receptor-mediated aquaporin 4 expression.
Wang ML; Huang XJ; Fang SH; Yuan YM; Zhang WP; Lu YB; Ding Q; Wei EQ
Biochem Biophys Res Commun; 2006 Nov; 350(2):399-404. PubMed ID: 17010308
[TBL] [Abstract][Full Text] [Related]
18. 5-Lipoxygenase products regulate basophil functions: 5-Oxo-ETE elicits migration, and leukotriene B(4) induces degranulation.
Iikura M; Suzukawa M; Yamaguchi M; Sekiya T; Komiya A; Yoshimura-Uchiyama C; Nagase H; Matsushima K; Yamamoto K; Hirai K
J Allergy Clin Immunol; 2005 Sep; 116(3):578-85. PubMed ID: 16159627
[TBL] [Abstract][Full Text] [Related]
19. Cysteinyl leukotriene 2 receptor-mediated vascular permeability via transendothelial vesicle transport.
Moos MP; Mewburn JD; Kan FW; Ishii S; Abe M; Sakimura K; Noguchi K; Shimizu T; Funk CD
FASEB J; 2008 Dec; 22(12):4352-62. PubMed ID: 18779380
[TBL] [Abstract][Full Text] [Related]
20. Etodolac, a selective cyclooxygenase-2 inhibitor, induces upregulation of E-cadherin and has antitumor effect on human bladder cancer cells in vitro and in vivo.
Okamoto A; Shirakawa T; Bito T; Shigemura K; Hamada K; Gotoh A; Fujisawa M; Kawabata M
Urology; 2008 Jan; 71(1):156-60. PubMed ID: 18242386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
